Signaevsky, Maxim
Marami, Bahram
Prastawa, Marcel
Tabish, Nabil
Iida, Megan A.
Zhang, Xiang Fu
Sawyer, Mary
Duran, Israel
Koenigsberg, Daniel G.
Bryce, Clare H.
Chahine, Lana M.
Mollenhauer, Brit
Mosovsky, Sherri
Riley, Lindsey
Dave, Kuldip D.
Eberling, Jamie
Coffey, Chris S.
Adler, Charles H.
Serrano, Geidy E.
White, Charles L. III
Koll, John
Fernandez, Gerardo
Zeineh, Jack
Cordon-Cardo, Carlos
Beach, Thomas G.
Crary, John F. https://orcid.org/0000-0002-0556-293X
Funding for this research was provided by:
National Institutes of Health (R01 AG054008, R01 NS095252, R01 NS086736, R01 AG062348)
Michael J. Fox Foundation for Parkinson's Research
Rainwater Charitable Trust
Javed and Shahnaz Iqbal Family Trust
Article History
Received: 20 October 2021
Accepted: 24 January 2022
First Online: 14 February 2022
Declarations
:
: All images were de-identified in accordance with the policies and regulation at the Icahn School of Medicine at Mount Sinai and its institutional review board.
: Bahram Marami, Marcel Prastawa, Mary Sawyer, Israel Duran, John Koll, Gerardo Fernandez, Jack Zeineh, and Carlos Cordon-Cardo disclose their relationship with PreciseDx™, an artificial intelligence-guided pathology diagnostics company, which has developed proprietary platform and AI algorithms used in this study.